With its team of experienced Chartered Accountants, bio101 provides a range of finance and administration solutions to private, public and listed companies in the Australian life sciences sector. These solutions include accounting, company secretarial, taxation, grant applications, payroll administration, business development, royalty and partner management.
BioImpact invests in and holds intellectual property rights for pharmaceuticals and medical devices for the development and commercialisation in the Asia/Pacific region. Technologies and products are sourced from a range of global third parties.
BTC Speciality Health commercialises and distributes the BTC health’s groups in licenced pharmaceuticals and medical devices in the Asia/ Pacific Region.
Sensear is a global leader in developing and manufacturing best-in-class digital over-the-ear and in-the-ear headsets for use with two-way radio and Bluetooth communication devices.
Founded in 2006, through a unique partnership with the University of Western Australia and Curtin University driven by industry demand, Sensear’s patented SENSTM technology simultaneously enhances speech, and suppresses background noise so that users can verbally communicate, protect their hearing, and still maintain 360-degree awareness of their surroundings in noisy environments such as gas, mining, construction, heavy manufacturing and other industrial work places.
Sensear partners with some of the world’s leading companies with helping them solve their high noise communication challenges. Sensear with its ISO 9001:2008 certification shows the companies commitment to the design, manufacture and repair of products that meet the demands of our customers’ high quality standards. Sensear is based in Belmont, Australia, with offices in North America.